ISDA

Deposition Date 2011-02-02

Release Date 2011-03-16

Last Version Date 2024-11-13

Entry Detail

PDB ID:

2Y7Z

Keywords:

BLOOD CLOTTING

Title:

Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs

Biological Source:

Source Organism:

HOMO SAPIENS (Taxon ID: 9606)

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.84 Å

R-Value Free:

0.24

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:ACTIVATED FACTOR XA HEAVY CHAIN
Gene (Uniprot):F10
Chain IDs:A
Chain Length:254
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P00742 Pfam ID:PF00089, PF00594, PF00008, PF14670 EC:3.4.21.6

Protein Blast

Polymer Type:polypeptide(L)
Molecule:FACTOR X LIGHT CHAIN
Gene (Uniprot):F10
Chain IDs:B
Chain Length:134
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P00742 Pfam ID:PF00089, PF00594, PF00008, PF14670 EC:3.4.21.6

Ligand Molecules

C0Z

Primary Citation

Structure and Property Based Design of Factor Xa Inhibitors: Pyrrolidin-2-Ones with Aminoindane and Phenylpyrrolidine P4 Motifs.

Young, R.J, Adams, C, Blows, M, Brown, D, Burns-Kurtis, C.L, Chan, C, Chaudry, L, Convery, M.A, Davies, D.E, Exall, A.M, Foster, G, Harling, J.D, Hortense, E, Irvine, S, Irving, W.R, Jackson, S, Kleanthous, S, Pateman, A.J, Patikis, A.N, Roethka, T.J, Senger, S, Stelman, G.J, Toomey, J.R, West, R.I, Whittaker, C, Zhou, P, Watson, N.S.Show

Bioorg.Med.Chem.Lett. 21 1582 ? (2011)

PMID: 21349710 DOI: 10.1016/J.BMCL.2011.01.131

Abstact

The rational design, syntheses and evaluation of potent sulfonamidopyrrolidin-2-one-based factor Xa inhibitors incorporating aminoindane and phenylpyrrolidine P4 motifs are described. These series delivered highly potent anticoagulant compounds with excellent oral pharmacokinetic profiles; however, significant time dependant P450 inhibition was an issue for the aminoindane series, but this was not observed with the phenylpyrrolidine motif, which produced candidate quality molecules with potential for once-daily oral dosing in humans.

Legend

Protein

Chemical

Disease

Primary Citation of related structures